Scholar Rock Holding Corp (SRRK)
About Scholar Rock Holding Corp
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$377.9M
- Total assets
- $404.3M
- Market cap
- $5.3B
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $384.6M
- Operating income
- -$384.6M
- Net income
- -$377.9M
- EPS (basic)
- $-3.29
- EPS (diluted)
- $-3.29
Balance sheet
- Total assets
- $404.3M
- Current assets
- $385.1M
- Total liabilities
- $158.8M
- Current liabilities
- $55.4M
- Shareholders’ equity
- $245.5M
Cash flow
- Operating cash flow
- -$300.0M
- Investing cash flow
- $218.7M
- Financing cash flow
- $228.4M
- Net cash flow
- $147.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.3B
- EPS (diluted)
- $-3.29
- Shares outstanding
- 111.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 24, 2018
Scholar Rock Holding Corp (SRRK) Stock Price
- Reported a net loss of $377.9M in FY2025.
- Trading 18% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Scholar Rock Holding Corp.
Write a review
News about Scholar Rock Holding Corp
News & sentiment via Polygon.io
Scholar Rock Holding Corp: frequently asked questions
Is Scholar Rock Holding Corp an American company?
Scholar Rock Holding Corp is a US-based company headquartered in Cambridge, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Scholar Rock Holding Corp headquartered?
Scholar Rock Holding Corp is headquartered in Cambridge, Massachusetts, United States.
Is Scholar Rock Holding Corp publicly traded?
Yes — Scholar Rock Holding Corp is a publicly traded company. Its stock trades under the ticker symbol SRRK on the NASDAQ.
What does Scholar Rock Holding Corp do?
Scholar Rock Holding Corp is an American Pharmaceuticals company in the Health & Beauty sector.
